✓ Credit card payment restored — secure checkout via Privacy Shield

Amlode

Amlode is amlodipine 5 / 10 mg tablets — the reference third-generation dihydropyridine CCB. 35-50h half-life = smoothest once-daily BP control of any CCB. ASCOT-BPLA trial evidence (beat atenolol+thiazide); VALUE trial. Standard dose 5-10 mg once daily. Also for chronic stable angina, Prinzmetal angina, Raynaud’s. Safely combinable with beta-blockers. Ankle oedema is the main side effect (up to 25% at 10 mg).

Medically reviewed by Morgan Ellis — Pharmacy Researcher · 8 years experience  · Last reviewed: May 2026

Buy more, save more Price per tablet
Select a strength above to see pack pricing.
Encrypted checkout
Crypto pays 10% less
Discreet worldwide delivery
1,400+ customers · 50+ countries

⚡ Quick Answer — What is Amlode?

Amlode is a 5 / 10 mg amlodipine tablet from a WHO-GMP certified manufacturer — a third-generation dihydropyridine calcium-channel blocker (CCB). Introduced 1990 (Pfizer as Norvasc / Istin). The reference DHP for hypertension worldwide. Plasma half-life 35-50 hours — the longest of any CCB and one of the longest half-lives in cardiovascular medicine. Amlodipine’s extremely long half-life means: (1) dose missed by a day has minimal effect, (2) gradual smooth onset with no reflex tachycardia (unlike short-acting nifedipine), (3) no need for sustained-release formulations, (4) can be paired safely with any other antihypertensive class including beta-blockers. Typical hypertension dose: 5 mg once daily (2.5 mg if elderly, small body size, or hepatic impairment); target 5-10 mg once daily. Main side effects: ankle (peripheral) oedema, flushing, headache from vasodilation, reflex tachycardia (blunted by amlodipine’s long half-life; common with IR nifedipine). Safe to combine with beta-blockers, ACE inhibitors, ARBs, and thiazides (unlike non-DHP CCBs). Pregnancy: nifedipine MR is pregnancy-safe and often first-line; amlodipine is reasonable second option.

What you get with MedsBase: WHO-GMP certified manufacturer · Discreet packaging · Worldwide shipping · 1,400+ verified customer reviews

📦 Every order is covered by our Reshipment Assurance Policy — if your parcel does not arrive within 20 business days, we reship it.

Why order from MedsBase

Our generic medications are sourced from WHO-GMP certified manufacturers and shipped worldwide in discreet, plain packaging — no medication name on the parcel exterior. Card payments are routed through a regulated processor (statement descriptors include a regulated card-payment processor — never “MedsBase” or any medication name). Crypto and SEPA bank transfer are also accepted. Every order is backed by our Reshipment Assurance Policy.

What Is Amlode?

Amlode is an oral 5 / 10 mg amlodipine tablet from a WHO-GMP certified manufacturer, supplied in 30-180 tablets. Introduced 1990 (Pfizer as Norvasc / Istin). The reference DHP for hypertension worldwide.

Amlodipine belongs to the dihydropyridine calcium-channel blocker subclass, distinguished from the non-dihydropyridines (diltiazem, verapamil) by its selective action on vascular smooth muscle with minimal direct cardiac effect. This selectivity profile is clinically important: DHPs can be combined safely with beta-blockers (the combination is standard in angina), while non-DHPs cannot (additive bradycardia/heart-block risk).

How Amlodipine Works

Calcium-channel blockers bind L-type voltage-gated calcium channels and reduce calcium influx into the cell during depolarisation. In arterial smooth muscle, reduced calcium entry means less actin-myosin interaction and direct arterial vasodilation — lowering systemic vascular resistance and blood pressure.

Dihydropyridines are ~10-fold more potent on vascular smooth muscle than on cardiac muscle — so the dominant clinical effect is vasodilation, with minimal direct suppression of cardiac contractility or conduction. The body’s baroreflex can trigger mild reflex tachycardia after fast-onset vasodilation; amlodipine’s very long onset eliminates this effect clinically.

Onset of clinical effect: gradual onset over 6-12 hours, full effect at 7-8 days.

Approved and Evidence-Based Uses

  • Uncomplicated hypertension — often first-line, particularly for Black patients and those over 55 (NICE, AHA)
  • Hypertension + stable angina (dual indication)
  • Prinzmetal / vasospastic angina — first-line
  • Raynaud’s phenomenon
  • Hypertension in heart failure with preserved ejection fraction (HF-pEF) — safer than non-DHP CCBs which are contraindicated in HF-REF
  • Hypertension in pregnancy — not first-line but reasonable second option after methyldopa / labetalol / nifedipine MR

Pivotal trial evidence: ASCOT-BPLA (2005) — perindopril + amlodipine beat atenolol + thiazide for CV outcomes in hypertension, establishing the modern preference for CCB + ACEi/ARB over beta-blocker + thiazide. VALUE (2004) — amlodipine-based therapy had slight advantage over valsartan-based therapy on stroke+MI endpoints, driven largely by faster BP drop. ALLHAT (2002) — amlodipine equivalent to chlorthalidone for most outcomes, better than lisinopril for stroke in black patients.

Amlode Dosage

Hypertension:

  • Starting dose: 5 mg once daily (2.5 mg if elderly, small body size, or hepatic impairment)
  • Target dose: 5-10 mg once daily
  • Maximum: 10 mg once daily
  • Titrate every 1-2 weeks based on BP response and tolerability (particularly oedema)

Angina: 5-10 mg once daily for chronic stable and vasospastic angina

Administration: once daily (or twice daily for IR nifedipine formulations). Swallow whole — do NOT crush or split extended-release formulations (delivers an IR dose with risk of hypotension). Take with or without food.

Discontinuation: no specific withdrawal syndrome; can be stopped without taper. BP will return to pre-treatment levels within 1-2 weeks.

Side Effects

Common (>5%, mostly mild and transient):

  • Peripheral (ankle) oedema — Peripheral (ankle) oedema from pre-capillary vasodilation — dose-related (up to 25% at 10 mg/day). Not from fluid overload; does not respond to diuretics. Management: reduce dose, combine with an ACE inhibitor or ARB (which neutralise the oedema via balanced pre-and-post-capillary vasodilation), or switch to a non-DHP CCB (diltiazem, verapamil) if the heart-rate effect is acceptable.
  • Flushing (warm face and upper body)
  • Headache (particularly at start of therapy; usually adapts within 2-4 weeks)
  • Minor palpitations (less common than with short-acting nifedipine)
  • Dizziness, postural hypotension
  • Fatigue
  • Mild constipation (less than non-DHPs)

Uncommon:

  • Rash, pruritus
  • Nausea, abdominal discomfort
  • Erectile dysfunction (rare)
  • Liver enzyme elevations (usually mild, reversible)
  • Rare reports of photosensitivity

Contraindications & Cautions

  • Known hypersensitivity to amlodipine or dihydropyridine class
  • Cardiogenic shock
  • Severe aortic stenosis (can cause critical hypotension)
  • Unstable angina or MI within 1 month (DHPs other than amlodipine)
  • Obstructive hypertrophic cardiomyopathy (reduces outflow gradient dynamically)
  • Severe hepatic impairment (all DHPs are hepatically metabolised)

Pregnancy: amlodipine is not first-line in pregnancy but has reassuring observational data; a reasonable second-line choice if labetalol, methyldopa, and nifedipine MR are ineffective or contraindicated.

Breastfeeding: small amounts in breast milk; generally considered acceptable with infant monitoring.

Drug Interactions

  • Grapefruit juice — inhibits CYP3A4 metabolism; can raise plasma levels of amlodipine and particularly nifedipine/nimodipine by 2-3×. Avoid on treatment days, or use consistently if at all.
  • Strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin, ritonavir, cobicistat) — raise CCB plasma levels; reduce dose or avoid
  • Strong CYP3A4 inducers (rifampicin, phenytoin, carbamazepine, St John’s wort) — reduce CCB plasma levels; may need dose increase
  • Simvastatin — amlodipine modestly increases simvastatin exposure; cap simvastatin at 20 mg/day when combined
  • Beta-blockers — DHPs combine safely with beta-blockers (the combination is standard in angina — beta-blocker blunts reflex tachycardia, CCB provides vasodilation). Distinct from non-DHP CCBs (diltiazem, verapamil) which should NOT be combined with beta-blockers.
  • Other antihypertensives — generally complementary; monitor BP
  • Sildenafil / tadalafil (PDE5 inhibitors for erectile dysfunction) — additive hypotension; caution particularly at high CCB doses

Calcium-Channel Blocker Class at a Glance

CCBClassNiche
Amlodipine (Amlode, Amlip)DHP (3rd gen)Reference DHP; once-daily HTN + angina; ASCOT evidence
Nifedipine (Depin, Nicardia Retard, Cardipin)DHP (1st gen)Pregnancy-safe MR; tocolysis; must use ER formulations for chronic HTN
Nimodipine (Nimodip)DHP (cerebrovascular)Subarachnoid haemorrhage vasospasm prevention — NOT for routine HTN
Diltiazem (Dilzem, Dilzem CD)Non-DHP (benzothiazepine)HTN + rate control + angina; moderate cardiac effect
Verapamil (Calaptin 40, Calaptin SR)Non-DHP (phenylalkylamine)Strongest cardiac effect; SVT, AF rate, cluster headache

DHP vs non-DHP — why it matters: DHPs (amlodipine, nifedipine) act selectively on arterial smooth muscle with minimal cardiac effect — safe to combine with beta-blockers. Non-DHPs (diltiazem, verapamil) slow AV nodal conduction and reduce cardiac contractility — do NOT combine with beta-blockers (additive bradycardia, heart block, acute heart failure risk). If your patient is already on a beta-blocker, use a DHP.

Storage

Store Amlode below 25°C. Protect from light. Keep out of reach of children.

Frequently Asked Questions

Why have my ankles started swelling after Amlode?

Peripheral oedema is a class effect of dihydropyridines, caused by pre-capillary arteriolar dilation that raises hydrostatic pressure in the lower-leg venules. It is NOT fluid overload and does NOT respond to diuretics. Management options: (1) reduce the CCB dose; (2) add an ACE inhibitor or ARB which balances pre- and post-capillary vasodilation and eliminates the oedema mechanism (often the preferred solution); (3) switch to a non-DHP CCB (diltiazem, verapamil) if rate-related side effects are acceptable; (4) leg elevation and compression stockings as adjuncts.

How long does Amlode take to lower blood pressure?

Gradual onset — measurable BP reduction within 24-48 hours; full effect at 7-8 days. Amlodipine’s extremely long half-life (35-50 h) gives one of the smoothest BP profiles in cardiovascular medicine.

Can I take Amlode with a beta-blocker?

Yes — DHPs combine safely with beta-blockers. The combination is standard in angina: the DHP vasodilates and reduces myocardial oxygen demand; the beta-blocker blunts the reflex tachycardia. This is different from non-DHP CCBs (diltiazem, verapamil) which should NOT be combined with beta-blockers due to additive bradycardia and heart-block risk.

Can I eat grapefruit on Amlode?

Grapefruit (juice and fresh fruit) inhibits CYP3A4 metabolism and can raise amlodipine plasma levels by 2-3×, increasing the risk of hypotension, dizziness, and oedema. Best practice: avoid grapefruit/juice while on CCBs, or consume consistently (your dose is titrated to BP response; sporadic grapefruit disrupts that).

Is Amlode safe in pregnancy?

Amlodipine is not first-line in pregnancy but has reassuring observational data; a reasonable second-line if labetalol, methyldopa, and nifedipine MR are ineffective or contraindicated. Discuss with your obstetrician.

Can I combine Amlode with my other BP medications?

Yes — DHP CCBs combine well with ACE inhibitors (ramipril, lisinopril), ARBs (losartan, telmisartan, olmesartan), beta-blockers (bisoprolol, metoprolol), and thiazide diuretics (HCTZ). The ACEi/ARB + CCB combination is particularly useful because it eliminates the ankle oedema side effect.

Where can I buy Amlode online?

You can buy Amlode (amlodipine 5 / 10 mg, 30-180 tablets) from MedsBase with discreet packaging and worldwide shipping.

Related Antihypertensives on MedsBase

⚕ Medical Disclaimer. This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Hypertension, heart failure, and arrhythmias require diagnosis, monitoring, and dose individualisation by a doctor — always use beta-blockers under medical guidance.

Related Alternatives

Other products in Chronic Conditions that customers also view:

More options in High Blood Pressure Medication

Ranked by recent MedsBase order volume — what other customers in this category are picking.

Strength

5 mg, 10 mg

Quantity

30 Tablet/s, 60 Tablet/s, 90 Tablet/s, 180 Tablet/s

Reviews

There are no reviews yet

Add a review
Amlode Amlode
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review

Q & A

Ask a question
Amlode Amlode
Your question
* Question is required
Name
* Name is required
There are no questions yet